15,854 Shares in Semler Scientific, Inc. (OTCMKTS:SMLR) Acquired by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC bought a new position in shares of Semler Scientific, Inc. (OTCMKTS:SMLRGet Rating) during the third quarter, HoldingsChannel.com reports. The firm bought 15,854 shares of the medical equipment provider’s stock, valued at approximately $595,000.

Other hedge funds have also recently bought and sold shares of the company. Bank of America Corp DE raised its stake in Semler Scientific by 4,042.1% during the first quarter. Bank of America Corp DE now owns 787 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 768 shares during the period. Royal Bank of Canada raised its stake in Semler Scientific by 2,585.7% during the first quarter. Royal Bank of Canada now owns 2,256 shares of the medical equipment provider’s stock worth $112,000 after purchasing an additional 2,172 shares during the period. Russell Investments Group Ltd. purchased a new position in Semler Scientific during the second quarter worth approximately $147,000. Veery Capital LLC purchased a new position in Semler Scientific during the third quarter worth approximately $225,000. Finally, Bank of New York Mellon Corp raised its stake in Semler Scientific by 101.7% during the first quarter. Bank of New York Mellon Corp now owns 5,106 shares of the medical equipment provider’s stock worth $253,000 after purchasing an additional 2,574 shares during the period. Institutional investors and hedge funds own 58.94% of the company’s stock.

Analyst Ratings Changes

Separately, B. Riley downgraded shares of Semler Scientific from a “buy” rating to a “neutral” rating and cut their price target for the stock from $60.00 to $45.00 in a research note on Wednesday, November 2nd.

Semler Scientific Trading Down 1.0 %

Shares of SMLR stock opened at $36.96 on Tuesday. The company’s fifty day simple moving average is $33.20 and its 200-day simple moving average is $36.40. Semler Scientific, Inc. has a 52 week low of $26.70 and a 52 week high of $82.00. The company has a market cap of $252.81 million, a PE ratio of 23.69 and a beta of 0.62.

Semler Scientific (OTCMKTS:SMLRGet Rating) last issued its earnings results on Tuesday, November 1st. The medical equipment provider reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.09. Semler Scientific had a net margin of 23.18% and a return on equity of 27.92%. The business had revenue of $14.05 million for the quarter, compared to the consensus estimate of $15.04 million.

Semler Scientific Company Profile

(Get Rating)

Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Read More

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (OTCMKTS:SMLRGet Rating).

Institutional Ownership by Quarter for Semler Scientific (OTCMKTS:SMLR)

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.